equipment Mr. Geza Perlaki Mr. Krishnan Subramanian Aylur Authorized Director Authorized Director Q3 2562 Q3 2561 FY 2562 FY 2561 อัตราผลตอบแทนต่อผู้ถือหุน้ (ROE) -1% 10% 4% 14% อัตราผลตอบแทนต่อสนิทรพัย ์(ROA

1.65 percent pursuant to the total value of consideration basis based on the consolidated financial statements as of 30 June 2019 which is a basis having the highest transaction value. The Company has

was 0.48x compared to that of last year at 0.55x. In 2019 the Company spent THB 1,784mn on capital expenditure and investment, primarily in investment properties, property, plant & equipment purchased

, Maharat Nakhon Ratchasima Hospital in Nakhon Ratchasima, Chonburi Hospital in Chonburi and Yala Hospital in Yala. The donations will go towards the purchase of medical equipment and supplies to support

. On the other hand, cash payments in short-term and long-term investments and investments used as collateral were Baht 467 million and cash payments in purchases of equipment and construction in

investing activities mainly resulted from payment for the M&E equipment of the MRT Blue Line Extension Project in the amount of Baht 2,952 Million, payment for constructions of the Si Rat-Outer Ring Road

to the changes in the following items: - Property, plant and equipment were 15,891.38 million Baht, increased by 630.43 million Baht mainly from progress of construction including clarified water

Company recorded dividend income in the amount of THB 686.30 million. 3.1.3 Property, plant and equipment increased in the amount of THB 3,366.93 million. The main reason was assets under construction of

Baht 10,294 million. Cash payments for short-term investments and investments used as short-term and long-term collateral were Baht 2,366 million. Cash payments for equipment and construction in progress

2019) of property, plant and equipment Mr. Geza Perlaki Mr. Krishnan Subramanian Aylur Authorized Director Authorized Director หน่วย: ล้านบาท FY 2563 YTD FY 2562 YTD YoY change YoY % change เงินสดและ